Pathology · Anemias (Hemolytic, Microcytic, Macrocytic, Hemoglobinopathies)

A 30-year-old Mediterranean woman has chronic hemolytic anemia, splenomegaly, target cells, HbA2 6.5%, and HbF 45% on electrophoresis. The molecular defect is:

  • A Beta-thalassemia major — severely reduced or absent beta-globin chain synthesis
  • B HbS — glutamate to valine substitution at beta-6
  • C Alpha-thalassemia trait — deletion of two alpha-globin genes
  • D HbC disease — glutamate to lysine substitution at beta-6
Correct answer: A. Beta-thalassemia major — severely reduced or absent beta-globin chain synthesis

Explanation

Beta-thalassemia major (Cooley anemia) shows severe reduction/absence of beta-globin chains, leading to excess alpha chains that precipitate and damage RBCs. Compensatory increase in HbF and HbA2 are characteristic, with HbA markedly reduced. HbS has Glu→Val at beta-6 causing sickling; HbC has Glu→Lys at beta-6 causing mild hemolysis; alpha-thalassemia trait does not cause elevated HbA2.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Anemias (Hemolytic, Microcytic, Macrocytic, Hemoglobinopathies) MCQs

See all Anemias (Hemolytic, Microcytic, Macrocytic, Hemoglobinopathies) MCQs →